AKT1 and melanoma: To further clarify whether the function of Piezo1 in regulating the malignant progression of melanoma was directly dependent on the PI3K/AKT/mTOR pathway, we treated wild-type A375 cells with the PI3K inhibitor LY294002, the Piezo1 activator Yoda1 and both.